IM Cannabis (IMCC) Total Non-Current Liabilities (2019 - 2026)
IM Cannabis (IMCC) recorded quarterly Total Non-Current Liabilities of $805772.3 in Q1 2026, down 16.46% quarter-over-quarter from $964481.1 in Q4 2025, and up 19.57% on a YoY basis from $673918.2 in Q1 2025.
IM Cannabis (IMCC) Total Non-Current Liabilities (2019 - 2026) Analysis & Trends
IM Cannabis' Total Non-Current Liabilities history runs 8 years deep, the most recent figure standing at $805772.3 for Q1 2026.
- In Q1 2026, Total Non-Current Liabilities rose 19.57% year-over-year to $805772.3; the TTM figure through Mar 2026 stood at $805772.3 (up 19.57% YoY), while the FY2025 annual figure was $964481.1, up 17.48% from the prior year.
- Total Non-Current Liabilities was $805772.3 for Q1 2026 at IM Cannabis, down from $964481.1 in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $21.8 million in Q1 2022 to a low of $673918.2 in Q1 2025.
- Historically, Total Non-Current Liabilities has averaged $4.0 million across 5 years, with a median of $1.7 million in 2023.
- The sharpest annual moves came in 2022 and 2025: Total Non-Current Liabilities plunged 85.0% in 2022, then jumped 37.91% in 2025.
- A 5-year view of Total Non-Current Liabilities shows it stood at $2.3 million in 2022, then dropped by 26.13% to $1.7 million in 2023, then plunged by 51.68% to $804614.4 in 2024, then grew by 19.87% to $964481.1 in 2025, then decreased by 16.46% to $805772.3 in 2026.
- The last three Total Non-Current Liabilities figures came in at $805772.3 (Q1 2026), $964481.1 (Q4 2025), and $1.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 18.28 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 11.64 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 599.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 44.12 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 1.24 Bn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 6.26 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 2.44 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1.13 Bn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 1.81 Bn |
| 10 | IM Cannabis | 57,090.22 | -728,264.31 | 1.03 Mn | 805,772.29 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 805,772.29 |
| Dec 31, 2025 | 964,481.05 |
| Sep 30, 2025 | 1.14 Mn |
| Jun 30, 2025 | 1.34 Mn |
| Mar 31, 2025 | 673,918.23 |
| Dec 31, 2024 | 804,614.43 |
| Sep 30, 2024 | 862,803.86 |
| Jun 30, 2024 | 973,879.21 |
| Mar 31, 2024 | 1.69 Mn |
| Dec 31, 2023 | 1.67 Mn |
| Sep 30, 2023 | 3.41 Mn |
| Jun 30, 2023 | 4.55 Mn |
| Mar 31, 2023 | 4.60 Mn |
| Dec 31, 2022 | 2.25 Mn |
| Sep 30, 2022 | 2.96 Mn |
| Jun 30, 2022 | 17.42 Mn |
| Mar 31, 2022 | 21.79 Mn |
| Dec 31, 2021 | 15.03 Mn |
| Dec 31, 2020 | 14.76 Mn |
| Dec 31, 2019 | 1.65 Mn |